Cargando…

The Impact of Retail-Sector Delivery of Artemether–Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial

BACKGROUND: It has been proposed that artemisinin-based combination therapy (ACT) be subsidised in the private sector in order to improve affordability and access. This study in western Kenya aimed to evaluate the impact of providing subsidized artemether–lumefantrine (AL) through retail providers o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kangwana, Beth P., Kedenge, Sarah V., Noor, Abdisalan M., Alegana, Victor A., Nyandigisi, Andrew J., Pandit, Jayesh, Fegan, Greg W., Todd, James E., Brooker, Simon, Snow, Robert W., Goodman, Catherine A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104978/ https://www.ncbi.nlm.nih.gov/pubmed/21655317 http://dx.doi.org/10.1371/journal.pmed.1000437

Ejemplares similares

Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya
por: Kedenge, Sarah V., et al.
Publicado: (2013)

The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial
por: Kangwana, Beth P, et al.
Publicado: (2013)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
por: Sudoi, Raymond K, et al.
Publicado: (2012)

Evaluating Different Dimensions of Programme Effectiveness for Private Medicine Retailer Malaria Control Interventions in Kenya
por: Abuya, Timothy O., et al.
Publicado: (2010)

A spatial national health facility database for public health sector planning in Kenya in 2008
por: Noor, Abdisalan M, et al.
Publicado: (2009)

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya
por: Noor, Abdisalan M, et al.
Publicado: (2006)

Translation of artemether–lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya
por: Zurovac, D, et al.
Publicado: (2008)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
por: Wasunna, Beatrice, et al.
Publicado: (2008)

Changing malaria intervention coverage, transmission and hospitalization in Kenya
por: Okiro, Emelda A, et al.
Publicado: (2010)

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study
por: Fegan, Greg W, et al.
Publicado: (2007)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
por: Sipilanyambe, Naawa, et al.
Publicado: (2008)

The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya
por: Wasunna, Beatrice, et al.
Publicado: (2015)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
por: Juma, Elizabeth A, et al.
Publicado: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, Dejan, et al.
Publicado: (2008)

Predicting the Unmet Need for Biologically Targeted Coverage of Insecticide-Treated Nets in Kenya
por: Noor, Abdisalan M., et al.
Publicado: (2010)

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
por: Obonyo, Charles O., et al.
Publicado: (2022)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Cluster Randomized Trial of Text Message Reminders to Retail Staff in Tanzanian Drug Shops Dispensing Artemether-Lumefantrine: Effect on Dispenser Knowledge and Patient Adherence
por: Bruxvoort, Katia, et al.
Publicado: (2014)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
por: Prah, James, et al.
Publicado: (2016)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
por: Dimbu, Pedro Rafael, et al.
Publicado: (2021)

Malaria paediatric hospitalization between 1999 and 2008 across Kenya
por: Okiro, Emelda A, et al.
Publicado: (2009)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
por: Zurovac, Dejan, et al.
Publicado: (2007)

The risks of malariainfection in Kenya in 2009
por: Noor, Abdisalan M, et al.
Publicado: (2009)

Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya
por: Watsierah, Carren A, et al.
Publicado: (2012)

A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
por: Agarwal, Aarti, et al.
Publicado: (2013)

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

Analyzing the equity of public primary care provision in Kenya: variation in facility characteristics by local poverty level
por: Toda, Mitsuru, et al.
Publicado: (2012)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
por: Patrocínio-Jesus, Rita, et al.
Publicado: (2019)

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
por: Diarra, Modibo, et al.
Publicado: (2021)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
por: Amponsah, Emmanuel Kofi, et al.
Publicado: (2021)

Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
por: Nyangulu, Wongani, et al.
Publicado: (2023)

Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
por: Ocan, Moses, et al.
Publicado: (2023)

Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether‐Lumefantrine for Uncomplicated Malaria
por: Chotsiri, Palang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1au05gfkvdvm52g6m1d0deh8nf